Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
Status:
Unknown status
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether capecitabine is effective to prevent
disease recurrence after curative hepatic resection in patients with hepatocellular
carcinoma.